Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Therapeutic intervention

Targeted treatment shows promise for severe spinal muscular atrophy

Antisense drug nusinersen was well tolerated in trial of 20 babies with SMA, with majority showing improved muscle skills and function after treatment.

Lumbar puncture being performed on a newborn baby

Source: Garo / Phanie / Science Photo Library

The majority of the 20 babies who were given nusinersen by lumbar puncture showed improvement in muscle skills and function

Infantile-onset spinal muscular atrophy (SMA) is the most severe form of the disease, and most babies diagnosed with the condition don’t live beyond two years without breathing and feeding support.

Nusinersen is an antisense drug that redirects a ‘back-up’ gene (SMN2) to produce a protein that is deficient in babies with SMA.

In a phase II open-label trial, researchers explored the effect of nusinersen delivered by lumbar puncture to 20 babies with SMA aged between three weeks and seven months.

An interim analysis, published in The Lancet[1] (online, 6 December 2016), shows the drug was well tolerated and there were no safety concerns over a maximum follow-up of 32 weeks.

The authors also observed improvement in muscle skills and function in the majority of babies and 16 babies survived without needing permanent breathing support.

The researchers conclude that their findings provide proof of principle for the use of antisense drugs such as nusinersen in neurological disorders.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202122

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • MCQs in Clinical Pharmacy

    MCQs in Clinical Pharmacy

    Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.

    £25.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Lumbar puncture being performed on a newborn baby

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.